Abstract
Administration to mice of electroconvulsive shock (ECS) five times over 10 days results in an enhanced 5-HTP-induced head twitch response, an enhanced apomorphine-induced locomotor response and an attenuated sedation response to the α2-adrenoceptor agonist clonidine. Diazepam (1.25 mg/kg IP) injected 5 min before each ECS abolished the enhanced 5-HT- and dopamine-mediated responses but left the attenuated sedation response unaltered. When diazepam was given 5 min after each convulsion it still had the same effect, although its effect on the ECS-induced changes was blocked by administration of the specific benzodiazepine antagonist Ro 15-1788 (10 mg/kg IP) at the same time as diazepam.
It is concluded that diazepam can abolish the ECS-induced changes in 5-HT- and DA-mediated behaviour, but not α2-adrenoceptor-mediated responses, possibly by interfering with post-ictal changes. The implications for administration of benzodiazepines during electroconvulsive therapy (ECT) are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bhavsar VH, Dhumal VR, Kelkar VV (1981) The effect of some antiepilepsy drugs on the enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats. Eur J Pharmacol 74:243–247
Brandon S, Cowley P, McDonald C, Neville P, Palmer R, Wellstood-Eason S (1984) Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. Br Med J 288:22–25
Corne SJ, Pickering RW, Warner BT (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol 20:106–120
Cowen PJ, Nutt DJ, Green AR (1980) Enhanced 5-hydroxytryptamine and dopamine mediated behavioural responses following convulsions — II The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock. Neuropharmacology 19:901–906
Drew GM, Gower AJ, Marriott AS (1979) 193-1 mediate clonidine-induced sedation in the rat. Br J Pharmacol 67:133–141
Evans JP, Grahame-Smith DG, Green AR, Tordoff AFC (1976) Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. Br J Pharmacol 56:193–199
Goodwin GM, Green AR, Johnson P (1984) 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated headtwitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83:235–242
Grahame-Smith DG, Green AR, Costain DW (1978) The mechanisms of the antidepressant action of ECT. Lancet i:254–257
Green AR (1984) Studies on the possible association between alterations in monoamine-mediated behaviour and biochemical changes which occur after repeated ECS. In: Lerer B, Weiner RD, Belmaker RH (eds) ECT: Basic mechanisms. John Libbey & Co, London, pp 5–17
Green AR, Heal DJ, Grahame-Smith DG (1977) Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology 52:195–200
Green AR, Heal DJ, Johnson P, Lawrence BE, Nimgaonkar VL (1983a) Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and domapine-mediated behaviours and 5-HT2 receptor number in frontal cortex. Br J Pharmacol 80:377–385
Green AR, Johnson P, Nimgaonkar VL (1983b) Increased 5-HT2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats. Br J Pharmacol 80:173–177
Green AR, Johnson P, Mountford JA, Nimgaonkar VL (1985) Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy. Br J Pharmacol 84:337–346
Green AR, Sant K, Bowdler JM, Cowen PJ (1982) Further evidence for a relationship between changes in GABA concentrations in rat brain and enhanced monoamine-mediated behaviours following repeated electroconvulsive shock. Neuropharmacology 21:981–984
Green AR, O'Shaughnessy K, Hammond M, Schächter M, Grahame-Smith DG (1983c) Inhibition of 5-hydroxytryptamine-mediated behaviours by the putative 5-HT2 antagonist pirenperone. Neuropharmacology 22:573–578
Green AR, Peralta E, Hong J-S, Mao CC, Atterwill CK, Costa E (1978) Alterations in GABA metabolism and met-enkephalin content in rat brain following repeated electroconvulsive shock. J Neurochem 31:607–611
Heal DJ, Akagi H, Bowdler JM, Green AR (1981) Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents. Eur J Pharmacol 75:231–237
Heal DJ, Lister S, Smith SL, Davies CL, Molyneux SG, Green AR (1983) The effects of acute and repeated administration of various antidepressant drugs on clonidine-induced hypoactivity in mice and rats. Neuropharmacology 22:983–992
Hunkeler W, Möhler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffmer R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:515–516
Johnstone EC, Deakin JFW, Lawler P et al. (1980) The Northwick Park ECT trial. Lancet ii:1317–1320
Johnstone EC, Deakin JFW, Lawler P et al. (1982) Benzodiazepines and effectiveness of ECT. Br J Psychiatr 141:314–315
Kellar KJ, Cascio CS, Butler JA, Kurtzke RN (1981) Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol 69:515–518
Lebrecht U, Nowak JZ (1980) Effects of single and repeated electroconvulsive shock on serotonergic system in rat brain II. Behavioural studies. Neuropharmacology 19:1055–1061
Modigh K (1975) Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. J Neural Transm 36:19–32
Ortmann R, Bischoff S, Radeke E, Beuch O, Delini-Stula A (1982) Correlations between different measurements of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn-Schmiedeberg's Arch Pharmacol 321:265–270
Peroutka SJ, Lebovitz RM, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 210:88–90
Stanford C, Nutt DJ (1982) Comparison of the effects of repeated ECS on α2-adrenoceptors in different regions of rat brain. Neuroscience 7:1753–1757
Strömgren LS, Dahl J, Fjeldborg N, Thomsen A (1980) Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy: anaesthetics and benzodiazepines. Acta Psychiatr Scand 62:158–165
Vetulani J, Lebrecht U, Pilc A (1981) Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. Eur J Pharmacol 76:81–85
Vetulani J, Szpak J, Pilc A (1983) Spaced electroconvulsive treatment: effects on responses associated with α- and 5-HT2-receptors. J Pharm Pharmacol 35:326–328
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Green, A.R., Mountford, J.A. Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment. Psychopharmacology 86, 190–193 (1985). https://doi.org/10.1007/BF00431707
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431707